This live web event has ended. Thank you for attending.
EGPA is a rare immune-mediated disease
characterized by adult-onset asthma , blood and tissue eosinophilia, and
small-vessel vasculitis thought to contribute to organ damage. In this
programme, divided into four segments, viewers will learn about the
pathophysiology, diagnosis, clinical complications associated with EGPA, and
multidisciplinary assessment of EGPA. References: 1. Trivioli G, et al.
Rheumatology (Oxford). 2020;59(Suppl 3):iii84-iii94; 2. Greco A, et al.
Autoimmun Rev. 2015;14:341-348. PSE-US-0717; 02/2022. This program is limited to Health Care Professionals (HCP) only. This is
a non-CME event. The industry program content and views expressed therein do
not necessarily reflect the views, policies or position of the American
This program is sponsored by GSK.
By registering for this webinar, you agree your information will be shared with the sponsor.
No CME or MOC credits are available for this program.
Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.